Skip to main content
. 2019 Nov 5;105(5):439–445. doi: 10.1136/archdischild-2019-317308

Table 2.

Demographic outline of the patients in the data sets

Leukaemia (%) Lymphoma (%) Solid tumours (%) Brain tumours (%) Median age (min-max) Outpatients (%) Poststem cell transplant (%) Central line in situ (%)
Leeds 11 (41) 3 (11) 10 (37) 3 (11) 67 months (15–219) 41 (85) 2 (7) 48 (100)
Liverpool 9 (43) 2 (9) 10 (48) 0 70 months
(8.5–228)
21 (100) 0 21 (100)
Sheffield 19 (40) 4 (9) 17 (36) 7 (15) 79 months (5–205) 150 (84) 15 (9) 161 (98)
Nottingham 37 (59) 1 (1.5) 19 (30) 6 (9.5) 48 months
(6–118)
155 (100) 4 (6) 141 (91)
Belgium 9 (56) 2 (13) 5 (31) 0 86 months (30–277) 0 1 (4) 24 (89)
Melbourne a 63 (62) 10 (10) 24 (24) 4 (4) 6 years (1–14) 101 (100) 0 62 (96)
Melbourne b 180 (55) 25 (8) 88 (27) 34 (10) 76 months (6.7–241) 648 (100) 15 (4) 310 (95)